Fig. 6From: Novel molecular typing reveals the risk of recurrence in patients with early-stage papillary thyroid cancerComprehensive assessment of DDR Recurrence Signature. A The RFS curve for early-stage PTC according to the ATA risk stratification. B The RFS curve for early-stage PTC according to the PBF/PTTG1 signature. C The application of the DDR signature in the entire TCGA cohort. D The application of the DDR signature in the TCGA cohort with BRAF mutationBack to article page